Subscribe To
Eur/usd held key support at 1.0681/69, rangebound phase to develop – credit suisse
EUR/USD has held key support at 1.0681/69. This reinforces our base case scenario of a lengthy period of ranging, with this level expected to define t...
February 9, 2023, 3:59 pm
Nexcella, inc. presents 42-patient interim data, with 90% overall response rate in relapsed or refractory multiple myeloma at nxc-201 therapeutic dose from its phase 1 expansion trial at the 5th europ
The poster presents data for 42 patients with relapsed or refractory multiple myeloma who were treated with NXC-201 (formerly HBI0101), of which 29 re...
February 9, 2023, 1:05 pm
Galapagos shares down after announcing clinical-trial miss for crohn's disease
U.S.-listed shares of Galapagos GLPG, +0.41% were down 8.9% in premarket trading on Thursday, the day after the company said an experimental treatment...
February 9, 2023, 8:35 am
Enphase energy may be offering investors a second chance
The morning after it reported strong fourth quarter earnings, Enphase Energy, Inc. (NASDAQ: ENPH) is pa...
February 9, 2023, 7:01 am
Cara therapeutics announces results from the komfort phase 2 trial of oral difelikefalin for the treatment of pruritus in notalgia paresthetica published in the new england journal of medicine
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment STAMFORD, Conn., Feb. 08...
February 8, 2023, 10:00 pm
Why enphase energy's stock popped then dropped today
Expectations for a slowdown in some of Enphase's business in the first quarter took the air out of the stock today....
February 8, 2023, 11:44 am
Enphase energy (enph) q4 earnings beat, revenues rise y/y
Enphase Energy's (ENPH) Q4 revenues of $724.7 million beat the Zacks Consensus Estimate by 2.9%. The to...
February 8, 2023, 10:32 am
Western magnesium sees its commercial pilot plant move into continuous metal production phase
Western Magnesium Corp. (TSX-V:WMG, OTCQB:MLYF) revealed that its commercial pilot plant is ready to move into the final stage of continuous metal pr...
February 8, 2023, 9:44 am
Sequana medical announces the successful completion of pre-clinical studies with its second-generation dsr product for congestive heart failure
PRESS RELEASE Data from GLPi animal studies demonstrate safety of second-generation DSRii product (DSR 2.0)Data from ...
February 8, 2023, 6:29 am
Enphase energy, inc. (enph) q4 2022 earnings call transcript
Enphase Energy, Inc. (NASDAQ:ENPH ) Q4 2022 Earnings Conference Call February 7, 2023 4:30 PM ET Compan...
February 7, 2023, 11:42 pm
Novocure: ramifications of recent management change
As NovoCure Limited delivers hope in seemingly hopeless situations, Tumor Treating Field is already launched for mesothelioma and glioblastoma multifo...
February 7, 2023, 6:24 pm
Enphase stock rallies 7% after q4 earnings blow past expectations
Enphase Energy Inc. ENPH, +2.45% share jumped more than 7% in the extended session Tuesday after the ma...
February 7, 2023, 4:46 pm
Indaptus therapeutics activates morristown medical center as trial site in indp-d101, its ongoing phase 1 open label clinical trial of decoy20 in patients with advanced solid tumors
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company ...
February 7, 2023, 1:05 pm
Why is kiora pharmaceuticals (kprx) stock up 61% today?
Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is heading higher on Tuesday thanks to an update on its KIO-101 eye drops. The big news here is the treatm...
February 7, 2023, 9:21 am
National labs, wabtec partner to develop next-gen locomotive engine
Rail technology provider Wabtec (NYSE: WAB) and scientists with the U.S. Department of Energy's Oak Ridge National Laboratory and the Argonne National...
February 7, 2023, 8:15 am
Immunic: multiple sclerosis data in h2 2023 could provide major shift
Interim results from the phase 2 CALLIPER study using IMU-838 for treatment of patients with Progressiv...
February 7, 2023, 7:22 am
Provention bio: ability to expand t1d market presence with second half 2023 data
Received FDA approval of TZIELD for Stage 2 Type 1 Diabetes patients in November of 2022. Potential to increase market potential of TZIELD with ongoin...
February 7, 2023, 6:28 am
Verona pharma: small biotech targeting $10bn copd market with a late stage drug
Verona Pharma is a UK-based biotech with a $1.6Bn market cap developing a phase 3 asset targeting COPD....
February 7, 2023, 6:01 am
Tonix pharmaceuticals initiates enrollment in phase 2 ‘prevention’ study of potentiated intranasal oxytocin (tnx-1900) for the prevention of migraine headaches in chronic migraineurs
Results from Planned Interim Analysis Expected Fourth Quarter 2023 Approximately Four Million in U.S. Suffer from Chronic Migraine Development of TNX-...
February 6, 2023, 12:00 pm
88 energy investors eye fresh catalysts as explorer starts alaska well countdown
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) almost never finds itself stuck in the mud and as one project phases into another, investors always seem t...
February 6, 2023, 9:01 am